KREBS BIOCHEMICALS & INDUSTRIES
Back to Income Statement
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹50 Cr | ₹52 Cr | ₹60 Cr | ₹54 Cr | ₹33 Cr |
What is the latest Revenue of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹52 Cr |
| Mar2023 | ₹60 Cr |
| Mar2022 | ₹54 Cr |
| Mar2021 | ₹33 Cr |
How is Revenue of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹50 Cr | -3.28 | |
| Mar2024 | ₹52 Cr | -12.68 | |
| Mar2023 | ₹60 Cr | 11.18 | |
| Mar2022 | ₹54 Cr | 60.72 | |
| Mar2021 | ₹33 Cr | - | |
Compare Revenue of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹128.5 Cr | -2.5% | 20.5% | -28.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | 1% | -6.4% | -0.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,862.0 Cr | 3.5% | 3.4% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,912.0 Cr | 0.2% | -1.8% | 33.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,891.0 Cr | -0.2% | -3.4% | 11.4% | Stock Analytics | |
| CIPLA | ₹99,591.5 Cr | 1.5% | -5.4% | -15.4% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | -2.5% |
20.5% |
-28.4% |
| SENSEX | 3.2% |
5% |
5.5% |
You may also like the below Video Courses